Development and validation of an explainable neural network model for predicting progression in type 2 diabetic kidney disease
Source check: Source checked. Not independent scientific confirmation.
Finding: An explainable neural-network model predicted progression of type 2 diabetic kidney disease from clinical indicators, with development and validation reported; findings are retrospective and cohort-bound.
Technology: An explainable neural network uses clinical indicators to predict progression of type 2 diabetic kidney disease.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- An explainable neural network uses clinical indicators to predict progression of type 2 diabetic kidney disease.
- Test and result
- An explainable neural-network model predicted progression of type 2 diabetic kidney disease from clinical indicators, with development and validation reported; findings are retrospective and cohort-bound. Reported comparison, experimental confirmation or held-out evaluation was checked; reason limits interpretation to the evidence.
- Limitation / still unknown
- The study does not establish performance or consequences beyond the reported cohort, datasets, task or experimental setup.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://doi.org/10.3389/fendo.2026.1858808 · https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2026.1858808/full
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.